Elizabeth Weise, USA TODAY

Elizabeth Weise

USA TODAY

San Francisco, CA, United States

Contact Elizabeth

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • USA TODAY
Past:
  • The Columbus Dispatch
  • Enquirer
  • Detroit Free Press
  • Indianapolis Star
  • North Jersey News
  • Salina Journal
  • CJOnline
  • DelmarvaNow!
  • Tallahassee Democrat
  • A-J Media
  • and more…

Recent articles by Elizabeth:

Australian Sudden Infant Death Syndrome study 'provocative' but not yet a breakthrough

A preliminary study out of Australia offers a tantalizing hint at what might cause SIDS, but doctors warn more research is needed. → Read More

After Roe? Pregnancy-related deaths could rise 20% or more in states that outlaw abortion, experts say.

If Roe v. Wade falls and abortion is outlawed in some states, pregnancy-related deaths could rise 20% or more, according to some calculations. → Read More

'A year after year disaster:' The American West could face a 'brutal' century under climate change

Models show the American West faces more fires, floods and air pollution this century if meaningful climate action isn't taken soon. → Read More

Russia's attack on a nuclear plant was unprecedented. Experts now fret about futures once thought 'inconceivable.'

The Zaporizhzhia attack was surprising given Russia's ties to the Chernobyl nuclear disaster, experts say. They worry more danger lies ahead. → Read More

Here comes the sun: Wind, solar power account for record 13% of U.S. energy in 2021

Solar and wind energy last year grew at the fastest rate in U.S. history and now account for a record 13% of U.S. power generation, according to a report released Thursday. → Read More

Here comes the sun: Wind, solar power account for record 13% of U.S. energy in 2021

Solar and wind energy last year grew at the fastest rate in U.S. history and now account for a record 13% of U.S. power generation, according to a report released Thursday. → Read More

FDA to consider two Pfizer COVID-19 vaccine shots for children under 5

Pfizer and its partner BioNTech have asked the Food and Drug Administration to allow their COVID vaccine to be used in children 4 years to 6 months old. → Read More

'Shame on us': Public health in America at a breaking point as pandemic enters third year

Business as usual won't be enough to combat the next public health crisis, experts say. The U.S. must tackle long-standing health problems, too. → Read More

Full vaccination against COVID-19 and a breakthrough infection builds 'super immunity,' study finds

A study by Oregon researchers finds that people fully vaccinated against COVID-19 who have a breakthrough infection end up with what the authors call "super immunity." They caution the vaccinated should not seek COVID-19 infection, but the "hybrid immunity" offers some solace for those whocatch one despite having been vaccinated. → Read More

CDC panel recommends Pfizer, Moderna COVID vaccines over Johnson & Johnson for people 18 and older

A CDC panel recommended the Pfizer and Moderna COVID-19 vaccines be preferred over J&J's due to the chance of rare but dangerous blood clots. → Read More

Omicron is spreading 'every place at once,' experts say. What it could mean for holiday plans.

A group of Massachusetts-based researchers say they believe omicron could already account for about 15% of COVID-19 cases in some parts of the U.S. → Read More

Omicron is spreading 'every place at once,' experts say. What it could mean for holiday plans.

A group of Massachusetts-based researchers say they believe omicron could already account for about 15% of COVID-19 cases in some parts of the U.S. → Read More

Omicron could be more contagious, less dangerous. That would be 'good news for the human race.'

Early reports from South Africa seem to show omicron is highly infectious but not "as virulent or as pathogenic as the delta variant" of coronavirus. → Read More

An early glimpse of omicron's threat: High transmission likely, but vaccines provide hope

Many experts believe vaccines will likely continue protecting against severe disease, but the mutated variant may prove highly infectious. → Read More

Is this the fifth COVID-19 wave? Experts fear we may simply come to call it 'winter'

COVID-19 case counts are up in nearly 30 states, especially in the north. Experts say the latest surge underscores the virus is here to stay. → Read More

'It's been a hell of a few weeks': Dave Chappelle launches film tour, ignoring outrage over trans comments

Dave Chappelle drew condemnation last month for his Netflix special 'The Closer,' but fans were wowed by his 'Untitled' documentary Thursday night. → Read More

CDC panel recommends Pfizer COVID vaccine for kids 5-11, shots expected to roll out this week

CDC experts find the benefits of Pfizer's COVID vaccine for kids 5 -11 outweigh potential risks. With final OK by director, shots to begin this week. → Read More

FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11

In children ages 5-11, the Pfizer-BioNTech vaccine was more than 90% protective against contracting symptomatic COVID-19, according to company data. → Read More

Pick any vaccine: CDC OKs COVID boosters – even mixing and matching – beginning as soon as Friday

Americans are now free to get a free booster dose of all three COVID-19 vaccines. The CDC has OK'd mixing and matching vaccines, too. → Read More

CDC advisory panel clears the way for J&J, Moderna and mix-and-match COVID boosters

Quick approval by the CDC director is expected, allowing J&J, Moderna and mix-and-match boosters to be given within days. → Read More